Gapping up
In reaction to strong earnings/guidance:
- NIO +3.5%, VIVO +1%
M&A news:
- APU +5.8% (to be acquired by UGI (UGI) for approximately $35.33/unit in cash & stock)
Select metals/mining stocks trading higher:
- HMY +2.8%, SBGL +2.4%, GFI +2.2%, MUX +2.1%, AU +2%
Other news:
- ADMA +70.3% (FDA approval of ASCENIV, Immune Globulin Intravenous, Human -- slra 10% Liquid)
- AVEO +15.3% (AVEO Oncology and Biodesix announce positive phase 1B results)
- SGMO +11.9% (Sangamo Therapeutics and Pfizer (PFE) announce data from the Phase 1/2 Alta study evaluating investigational SB-525 gene therapy for severe hemophilia A),
- OSTK +6.5% (in sympathy with Bitcoin's recent rise)
- SONO +1.5% (initiated with Buy at DA Davidson)
- KAR +1.1% (receives favorable IRS private letter ruling on tax-free nature of its previously announced salvage auction business spin-off)
Analyst comments:
- COMM +4.8% (upgraded to Outperform from Neutral at Credit Suisse)
- EMKR +4.6% (upgraded to Buy from Neutral at B. Riley FBR)
- QRVO +2.4% (upgraded to Overweight from Sector Weight at KeyBanc Capital Markets)
- DGX +1% (upgraded to Buy from Hold at Jefferies)